Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

{"Macrocyclic":[0],"peptides":[1],"have":[2],"emerged":[3],"as":[4,50],"a":[5],"compelling":[6],"class":[7],"of":[8,16,26,68,82,127],"therapeutics,":[9],"combining":[10],"the":[11,20,125],"modularity":[12],"and":[13,23,33,40,56,85,97,119],"synthetic":[14],"accessibility":[15],"small":[17],"molecules":[18],"with":[19],"high":[21],"affinity":[22],"target":[24],"selectivity":[25],"biologics.":[27],"Their":[28],"ability":[29],"to":[30,61,104],"engage":[31],"challenging":[32],"traditionally":[34],"\\"undruggable\\"":[35],"protein":[36],"targets-including":[37],"protein-protein":[38],"interactions":[39],"allosteric":[41],"sites-has":[42],"generated":[43],"widespread":[44],"interest.":[45],"However,":[46],"pharmacokinetic":[47],"limitations":[48],"such":[49],"poor":[51],"oral":[52],"bioavailability,":[53],"metabolic":[54],"instability,":[55],"low":[57],"membrane":[58],"permeability":[59],"continue":[60],"hinder":[62],"clinical":[63,94],"translation.":[64],"The":[65],"strategic":[66],"incorporation":[67],"unnatural":[69],"amino":[70],"acids":[71],"(UAAs)":[72],"has":[73],"proven":[74],"critical":[75],"for":[76],"overcoming":[77],"these":[78],"challenges,":[79],"enabling":[80],"fine-tuning":[81],"key":[83],"physicochemical":[84],"pharmacological":[86],"properties.":[87],"In":[88],"this":[89],"review,":[90],"we":[91],"highlight":[92],"recent":[93],"advances-including":[95],"motixafortide":[96],"zilucoplan-and":[98],"examine":[99],"how":[100],"UAAs":[101],"are":[102],"deployed":[103],"optimize":[105],"drug-like":[106],"characteristics":[107],"across":[108],"diverse":[109],"therapeutic":[110],"areas.":[111],"We":[112],"discuss":[113],"emerging":[114],"strategies,":[115],"illustrative":[116],"case":[117],"studies,":[118],"design":[120],"principles":[121],"that":[122],"collectively":[123],"support":[124],"development":[126],"next-generation":[128],"macrocyclic":[129],"peptide":[130],"drugs.":[131]}